Arbutus Biopharma Corp (ABUS)

Sales/Maturities of Investments

$22.00M

Quarterly · Period ending: · USD

ABUS logo

ABUS Sales/Maturities of Investments

Latest reported$22.00M
ABUS Quarterly Sales/Maturities of Investments ($0.00 → $22.00M)
High-resolution chart · PNG

ABUS sales/maturities of investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Arbutus Biopharma Corp Sales/Maturities of Investments — Quarterly (USD)
Period endingSales/Maturities of Investments (USD)
22,000,000
16,000,000
23,831,000
41,281,000
44,100,000
46,065,000
56,688,000
28,350,000
42,415,000
37,186,000
46,244,000
17,526,000
31,500,000
37,000,000
26,000,000
19,000,000
9,000,000
2,000,000
20,000,000
16,000,000
14,000,000
20,350,000
6,850,000
19,600,000
24,980,000
21,968,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-4,538,297
4,538,296
-348,227
2,464,846
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.